Mitiglinide calcium was quantitated by multiple reaction monitoring (MRM) mode with negative electrospray ionization (ESI -).
采用电喷雾负离子化，多反应监测(MRM)进行定量分析。
The invention provides a formula for preparing a tablet or capsule for treating diabetes from Mitiglinide calcium and a production process thereof.
本发明提供一种应用米格列奈钙制备用于治疗糖尿病的片剂或胶囊的配方及其生产工艺。
Objective:To establish a simple, sensitive method of high performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) for determination of mitiglinide calcium in human plasma.
目的：建立一种简便、灵敏的测定人血浆中米格列奈钙浓度的高效液相色谱-串联质谱 （HPLC-MS/MS）方法。
Conclusion Mitiglinide and Nateglinide have a certain inhibitory effect on oxidative stress of diabetic nephropathy patients, and has protective effect on kidney of patients, it is worth popularizing.
结论氯沙坦对糖尿病肾病患者氧化应激有一定的抑制作用，对患者的肾脏具有保护作用，值得临床关注。
Conclusion Mitiglinide and Nateglinide have a certain inhibitory effect on oxidative stress of diabetic nephropathy patients, and has protective effect on kidney of patients, it is worth popularizing.
结论氯沙坦对糖尿病肾病患者氧化应激有一定的抑制作用，对患者的肾脏具有保护作用，值得临床关注。
应用推荐